SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
27 views 864 days ago -
Watch Later
34:00Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?
27 views 1120 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
31 views 865 days ago -
Watch Later
!["Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH]()
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
23 views 824 days ago -
Watch Later
!["Updates in Adult Minimal Change Disease" presented by Ruth Campbell]()
51:21"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
32 views 845 days ago -
Watch Later
!["Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell]()
37:35"Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell
28 views 845 days ago
